NZ502129A - Cloning using donor nuclei from non-serum starved, differentiated cells - Google Patents
Cloning using donor nuclei from non-serum starved, differentiated cellsInfo
- Publication number
- NZ502129A NZ502129A NZ502129A NZ50212998A NZ502129A NZ 502129 A NZ502129 A NZ 502129A NZ 502129 A NZ502129 A NZ 502129A NZ 50212998 A NZ50212998 A NZ 50212998A NZ 502129 A NZ502129 A NZ 502129A
- Authority
- NZ
- New Zealand
- Prior art keywords
- disease
- cells
- cell
- differentiated
- offspring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8771—Bovine embryos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/02—Cells from transgenic animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Psychology (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88828397A | 1997-07-03 | 1997-07-03 | |
PCT/US1998/012800 WO1999001163A1 (en) | 1997-07-03 | 1998-06-24 | Cloning using donor nuclei from non-serum starved, differentiated cells |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ502129A true NZ502129A (en) | 2005-02-25 |
Family
ID=25392916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ502129A NZ502129A (en) | 1997-07-03 | 1998-06-24 | Cloning using donor nuclei from non-serum starved, differentiated cells |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1017422A4 (de) |
JP (1) | JP2001509361A (de) |
CN (2) | CN1265599A (de) |
AU (1) | AU8154398A (de) |
BR (1) | BR9811657A (de) |
CA (1) | CA2294916A1 (de) |
IL (1) | IL133786A0 (de) |
NZ (1) | NZ502129A (de) |
WO (1) | WO1999001163A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235969B1 (en) * | 1997-01-10 | 2001-05-22 | University Of Massachusetts | Cloning pigs using donor nuclei from non-quiescent differentiated cells |
DE59812083D1 (de) * | 1998-01-16 | 2004-11-11 | Agrobiogen Gmbh | Effizienter kerntransfer mit fetalen fibroblasten |
US6331659B1 (en) | 1998-01-21 | 2001-12-18 | University Of Hawaii | Cumulus cells as nuclear donors |
WO1999046982A1 (en) * | 1998-03-16 | 1999-09-23 | Relag Pty Ltd | Porcine nuclear transfer |
AUPP294898A0 (en) * | 1998-04-15 | 1998-05-07 | Monash University | Method of nuclear transfer |
EP1375654A3 (de) * | 1998-11-02 | 2008-01-16 | GTC Biotherapeutics, Inc. | Transgen- und klonierte Saugentiere |
EP1818397A1 (de) * | 1998-11-02 | 2007-08-15 | Trustees Of Tufts College | Verfahren zur Klonierung von Tieren |
WO2000025578A2 (en) * | 1999-04-26 | 2000-05-11 | Trustees Of Tufts College | Methods for cloning animals |
US6781030B1 (en) | 1998-11-02 | 2004-08-24 | Trustee Of Tufts College, Ballou Hall | Methods for cloning mammals using telophase oocytes |
WO2000051424A2 (en) | 1999-03-04 | 2000-09-08 | Ppl Therapeutics (Scotland) Ltd. | Genetic modification of somatic cells and uses thereof |
WO2001000794A1 (en) * | 1999-06-30 | 2001-01-04 | Hwang, Woo-Suk | Method for producing cloned tigers by employing inter-species nuclear transplantation technique |
RU2216591C2 (ru) * | 1999-06-30 | 2003-11-20 | Воо-Сук ХВАНГ | Способ получения клонированных эмбрионов человека путем применения способа межвидовой трансплантации ядер |
RU2205536C2 (ru) * | 1999-06-30 | 2003-06-10 | Воо-Сук ХВАНГ | Способ получения клонированной коровы |
BR0014864A (pt) | 1999-10-15 | 2002-11-19 | Advanced Cell Tech Inc | Métodos de produzir células progenitoras diferenciadas e células tronco embriÈnicas defeituosas em linhagem |
AU2000250770A1 (en) * | 2000-06-08 | 2001-12-17 | Trostner, Jens | Method for the genetic reconstruction of human organs |
WO2002012437A2 (en) | 2000-08-03 | 2002-02-14 | Schooten Wim Van | Production of humanized antibodies in transgenic animals |
FR2814642B1 (fr) | 2000-10-03 | 2005-07-01 | Ass Pour Le Dev De La Rech En | Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee |
NZ526243A (en) * | 2000-11-30 | 2006-02-24 | Stemron Inc | Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same |
EP2138583A1 (de) | 2000-12-22 | 2009-12-30 | Institut National De La Recherche Agronomique | Positionsunabhängige und gewebespezifische Expression eines Transgens in der Milch eines Transgen-Tieres |
MXPA03005624A (es) * | 2000-12-22 | 2004-12-03 | Vaurox Llc | Metodos para clonar mamiferos usando cromatina reprogramada del donador o celulas donadoras. |
WO2003025159A1 (en) | 2001-08-13 | 2003-03-27 | Embrex, Inc. | Methods for injecting avian eggs |
NZ535367A (en) * | 2002-04-01 | 2008-01-31 | Gtc Biotherapeutics Inc | A method for selecting cell lines to be used for nuclear transfer in mammalian species |
US7612250B2 (en) | 2002-07-29 | 2009-11-03 | Trustees Of Tufts College | Nuclear transfer embryo formation method |
CN101506235B (zh) | 2006-09-01 | 2012-07-25 | 人类多细胞株治疗学公司 | 人或人源化免疫球蛋白在非人转基因动物中增强的表达 |
EP2267153A1 (de) | 2009-05-26 | 2010-12-29 | Université Claude Bernard Lyon 1 | Identifizierung der Netrin-1-Rezeptor-unc5c-Genmutation bei festen Krebsen |
WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE213771T1 (de) * | 1993-12-23 | 2002-03-15 | Infigen Inc | Embryonale stammzellen von huftieren als kerndonatoren und kerntransfertechniken zur herstellung chimärer und transgener tiere |
GB9517780D0 (en) * | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
GB9517779D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
DE59812083D1 (de) * | 1998-01-16 | 2004-11-11 | Agrobiogen Gmbh | Effizienter kerntransfer mit fetalen fibroblasten |
-
1998
- 1998-06-24 CN CN98807691A patent/CN1265599A/zh active Pending
- 1998-06-24 JP JP2000500926A patent/JP2001509361A/ja active Pending
- 1998-06-24 CA CA002294916A patent/CA2294916A1/en not_active Abandoned
- 1998-06-24 IL IL13378698A patent/IL133786A0/xx unknown
- 1998-06-24 BR BR9811657-6A patent/BR9811657A/pt not_active Application Discontinuation
- 1998-06-24 AU AU81543/98A patent/AU8154398A/en not_active Abandoned
- 1998-06-24 EP EP19980931400 patent/EP1017422A4/de not_active Withdrawn
- 1998-06-24 CN CNA2007100081920A patent/CN101003800A/zh active Pending
- 1998-06-24 WO PCT/US1998/012800 patent/WO1999001163A1/en active Application Filing
- 1998-06-24 NZ NZ502129A patent/NZ502129A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2294916A1 (en) | 1999-01-14 |
IL133786A0 (en) | 2001-04-30 |
EP1017422A1 (de) | 2000-07-12 |
AU8154398A (en) | 1999-01-25 |
WO1999001163A1 (en) | 1999-01-14 |
CN1265599A (zh) | 2000-09-06 |
BR9811657A (pt) | 2000-09-05 |
JP2001509361A (ja) | 2001-07-24 |
CN101003800A (zh) | 2007-07-25 |
EP1017422A4 (de) | 2002-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU742363B2 (en) | Nuclear transfer with differentiated fetal and adult donor cells | |
AU740709B2 (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplanta tion | |
US6235969B1 (en) | Cloning pigs using donor nuclei from non-quiescent differentiated cells | |
US6215041B1 (en) | Cloning using donor nuclei from a non-quiesecent somatic cells | |
NZ502129A (en) | Cloning using donor nuclei from non-serum starved, differentiated cells | |
US20010012513A1 (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation | |
US20050095704A1 (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation | |
AU2006202185A1 (en) | Cloning using donor nuclei from non-serum starved, differentiated cells | |
AU2011202964A1 (en) | Nuclear transfer with differentiated fetal and adult donor cells | |
AU2006236032A1 (en) | Nuclear transfer with differentiated fetal and adult donor cells | |
MXPA00000201A (en) | Cloning using donor nuclei from non-serum starved, differentiated cells | |
Stice | Cloning using donor nuclei from a non-quiesecent somatic cells | |
MXPA99006464A (en) | Nuclear transfer with differentiated fetal and adult donor cells | |
MXPA99001706A (es) | Lineas celulares embrionicas o similares a las desoporte producidas por transplante nuclear de especies cruzadas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) |